Advanced hodgkin lymphoma: a new era of therapy. - Wikidata - awgldk - TriplyDB

Advanced hodgkin lymphoma: a new era of therapy.

Advanced hodgkin lymphoma: a new era of therapy.

http://www.wikidata.org/entity/Q34194160

about

Decreased Prognostic Value of International Prognostic Score in Chinese Advanced Hodgkin Lymphoma Patients Treated in the Contemporary Era.Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern era.

P2860

Q37487600-1B04BD9C-CC99-4EC9-9A77-92CD36F8BE90 Q37687804-0AB976F4-34A6-40C4-8CEA-11C4DEB8CB16

P2860

Advanced hodgkin lymphoma: a new era of therapy.

http://www.wikidata.org/entity/Q34194160

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Advanced hodgkin lymphoma: a new era of therapy.

@ast

Advanced hodgkin lymphoma: a new era of therapy.

@en

Advanced hodgkin lymphoma: a new era of therapy.

@nl

type

label

Advanced hodgkin lymphoma: a new era of therapy.

@ast

Advanced hodgkin lymphoma: a new era of therapy.

@en

Advanced hodgkin lymphoma: a new era of therapy.

@nl

prefLabel

Advanced hodgkin lymphoma: a new era of therapy.

@ast

Advanced hodgkin lymphoma: a new era of therapy.

@en

Advanced hodgkin lymphoma: a new era of therapy.

@nl

P1433

Q34194160-08FA3AEA-25DD-4430-B8FA-EC804ECDFAFB

P1476

Q34194160-7A3BFEC8-82D1-40A5-9DC6-DEABD05614CE

P2093

Q34194160-15D6FE43-9297-4D4D-A242-E5F9A3BA2BDA

P2860

Q34194160-07775283-5EF3-4DAF-85CB-AA865DCCEDF5

Q34194160-0EC016FE-7D76-44BE-8E1C-465AF869729A

Q34194160-23818BA7-FA74-4EA1-B433-A02DCC8863DA

Q34194160-31A23C58-D470-4132-8547-54B216E5F271

Q34194160-3468060C-498C-46D1-83E4-A13588E6A1D8

Q34194160-4A0CCBE1-9254-47BC-8A67-9256F6C0FB77

Q34194160-546762B4-97D1-4C48-92B7-C4EEABD621A6

Q34194160-701B74BC-AD7D-4252-8D9D-453C9EC5E116

Q34194160-81243463-31BD-4757-A91A-C3DC334F0F30

Q34194160-828C9CEE-AA22-4EE8-A939-2A39690922B0

P304

Q34194160-AFACDA64-3A69-4832-80D7-BF2524494C3C

P31

Q34194160-1C048266-EEAC-4119-813C-EA0776343C14

Q34194160-a72af13a-6c44-4604-a688-924f1b763e13

P356

Q34194160-0EB64CB2-3E66-465C-8B31-F45ED79B826C

P433

Q34194160-22DF4293-9372-4813-8E96-2BCB44A42D9D

P478

Q34194160-233C2861-94F5-4C76-AA5F-E9F8BD13D750

P577

Q34194160-5C858803-7988-419A-9337-F326CA4E3ABA

P698

Q34194160-05002B08-549A-4CC4-BAF7-56C168238476

P932

Q34194160-ADEEBEEB-BA21-4ADC-AFDB-1EB45C835DB1

P356

P1433

Mediterranean journal of hematology and infectious diseases

P1476

Advanced hodgkin lymphoma: a new era of therapy.

@en

P2093

Eldad J Dann

http://www.w3.org/2001/XMLSchema#string

P2860

ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t

P304

e2014063

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4084/MJHID.2014.063

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25237476

http://www.w3.org/2001/XMLSchema#string

P932

4165498

http://www.w3.org/2001/XMLSchema#string